Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07393841

Molecular Indicators of Systematic Fitness

Status
Recruiting
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
VO Health, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to characterize associations between cardiorespiratory fitness, as measured by VO₂max/VO₂peak, and blood-based molecular measurements in adults. This is an observational study where research staff measures VO₂max/VO₂peak and collects fasted, resting blood samples on the same day. The main questions it aims to answer are: 1. Can a multi-analyte blood panel accurately predict directly measured VO₂max/VO₂peak? 2. How do these blood-based features vary across age, sex, and self-reported or documented physical activity profiles? 3. Are the predictor analytes able to capture changes in VO₂max/VO₂peak caused by a self-directed intervention (e.g., training for a marathon)? 4. What is the analytic reliability of the predictor biomarkers?

Detailed description

Prospective observational cohort with baseline cross-sectional assessment; optional longitudinal follow-up with repeat VO₂max and blood collection in a subset. No intervention is assigned by the investigators. The investigators are amassing a large dataset of diverse individuals with directly measured VO2max paired with blood samples to support robust biomarker development.

Conditions

Interventions

TypeNameDescription
OTHERThere is no intervention.The investigators are not administering an intervention for this study. To opportunistically capture prospective data, the investigators give participants the option for re-testing after a period of time where participants are undergoing a self-directed intervention (i.e., no influence of the research staff), such as training for a marathon or other fitness event.

Timeline

Start date
2026-01-05
Primary completion
2028-01-05
Completion
2028-05-10
First posted
2026-02-06
Last updated
2026-02-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07393841. Inclusion in this directory is not an endorsement.